-
1 Comment
Sinopharm Tech Holdings Limited is currently in a long term uptrend where the price is trading 7.0% above its 200 day moving average.
From a valuation standpoint, the stock is 128.1% more expensive than other stocks from the Technology sector with a price to sales ratio of 7.9.
Sinopharm Tech Holdings Limited's total revenue sank by 75.2% to $9M since the same quarter in the previous year.
Its net income has increased by 27.5% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 7.6% to $-10M since the same quarter in the previous year.
Based on the above factors, Sinopharm Tech Holdings Limited gets an overall score of 2/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| Sector | Technology |
| Industry | Software - Application |
| ISIN | KYG2159V1418 |
| Beta | 1.74 |
|---|---|
| Market Cap | 68M |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Sinopharm Tech Holdings Limited, an investment holding company, provides internet plus solution and supply chain services in the People's Republic of China and Hong Kong. The company is involved in the provision of internet plus solution services; and supply chain management, data analysis, and related services, as well as trading of medial and related products. It also distributes Chinese patent medicines and health products. The company was formerly known as China Vanguard You Champion Holdings Limited and changed its name to Sinopharm Tech Holdings Limited in June 2019. The company was founded in 1999 and is headquartered in Central, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8156.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
